Emapalumab Prevention of CAR-T Cell Associated Toxicities

Abroad (travel likely)RecruitingPHASE2

Conditions

Large B-cell Lymphoma · Relapsed Non-Hodgkin Lymphoma · Refractory Non-Hodgkin Lymphoma · Diffuse Large B Cell Lymphoma · Primary Mediastinal Large B-cell Lymphoma · High-grade B-cell Lymphoma · Follicular Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Matthew Frigault, MD) · MFRIGAULT@partners.org · 617-643-6175
Contact: Principal Investigator (Matthew Frigault, MD)
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Caron Jacobson, MD) · Caron_Jacobson@DFCI.HARVARD.EDU · (617)-632-5847

Study leads

Matthew Frigault, MD
Principal Investigator
Massachusetts General Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

SynKIR-310 for Relapsed/Refractory B-NHL

B Cell Lymphoma · NHL, Adult · Mantle Cell Lymphoma

Abroad (travel likely)RecruitingPHASE1

Denver, United States · Atlanta, United States

National Longitudinal Cohort of Hematological Diseases

Multiple Myeloma · Acute Myeloid Leukemia · Hemophilia

Abroad (travel likely)Recruiting

Tianjin, China

Real-World Study of DLBCL With Different Genetic Subtypes

DLBCL - Diffuse Large B Cell Lymphoma · Lymphoma

Abroad (travel likely)Recruiting

Shanghai, China

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Acute Leukemia · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE2

Seattle, United States